Position in WAT
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$18,376
New position
Shares Held
49
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#983
of 1,173 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Joseph Group Capital Management holds $2,765,005 across 7 Diagnostics & Research names. WAT ranks #3 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MEDP |
Medpace Holdings, Inc.
|
4,991 | $2,643,183 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
100 | $50,136 | |
| 3 | WAT |
Waters Corp /De/
This page
|
49 | $18,376 | |
| 4 | DHR |
Danaher Corp /De/
|
93 | $17,714 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
72 | $13,911 | |
| 6 | A |
Agilent Technologies, Inc.
|
84 | $11,157 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
20 | $10,528 |
All Filings in WAT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,376 | 49 | Shares | Sole | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||